Evidence map›Paper›PMID 39514394›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2024

[Superficial extraskeletal osteosarcoma. Case report].

Pedro Elí García-Esparza, Alejandra Mantilla Morales

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pedro Elí García-EsparzaInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Servicio de Anatomía Patológica. Ciudad de México, México.ORCID 0009-0005-3955-5702
Alejandra Mantilla MoralesInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Oncología, Anatomía Patológica. Ciudad de México, México.ORCID 0000-0002-5085-6216

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Osteosarcoma is the most common primary malignant bone neoplasm in young people. Presentation in non-bone tissues comprises 2 to 5% of all osteosarcomas and less than 1% of all soft tissue sarcomas. On rare occasions it presents as a superficial tumor, making it necessary to make a differential diagnosis with benign entities, such as pyogenic granuloma ossificans, and malignant neoplasms, with sarcomatoid differentiation such as carcinosarcoma and dedifferentiated melanoma. Accurate diagnosis requires correlation of the histological, macroscopic and imaging characteristics of the neoplasm, which is of great relevance since the biological behavior and treatment differ from that of bone osteosarcoma and dedifferentiated neoplasms. Clinical case: We present the case of a 52-year-old man with superficial extraskeletal osteosarcoma, with radiological and pathological characteristics characteristic of this neoplasm. Conclusions: Superficial extraskeletal osteosarcoma is extremely rare, representing less than 10% of extraskeletal osteosarcomas, histological evaluation and imaging studies are mandatory for diagnosis, and clinical history is useful both to rule out differential diagnoses and to contribute to the diagnosis. definitive. Superficial extraskeletal osteosarcoma was diagnosed in this patient based on histological criteria. However, the few findings reported prevent us from knowing the prognostic factors.

Indexed as

OsteosarcomaHumansMaleMiddle AgedSoft Tissue NeoplasmsBone NeoplasmsMiddle AgedOsteosarcomaSoft Tissue Neoplasms

Identifiers

PMID39514394
PMCPMC12143906

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.